1. HBW Insight
  2. >>Health
  3. >>Policy & Regulation

GSCF World Congress: Supporting The Global Self-Care Agenda

 
• By David Ridley

Building trust, collaboration with healthcare professionals and promoting self-care in Africa were among the topics discussed during the second session on day one of the GSCF's World Congress 2022. Speakers included Bayer's Abbie Lennox, FIP's Sham Moodley and the Self-Care Trailblazer Group's Sarah Onyango 

• Source: Alamy

“Our currency is trust. One of our biggest challenges today is understanding what trust means in self-care,” stated Abbie Lennox, global head of regulatory, medical, safety & product compliance at Bayer Consumer Health.

Kicking off the second session of the GSCF World Congress, Lennox noted that when talking about self-care, it is easy...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Policy & Regulation

More from Health

UK Government Recognizes Crucial Role Of OTCs In Medicines Supply Chain

 
• By David Ridley

Representing about a fifth of all licensed medicines in the UK, OTCs are considered a critical part of the country's health system, according to a recently published Department of Health and Social Care (DHSC) paper on UK medicines supply issues.

Combat Meth Act PSE Daily Purchase Limit Once Too High For States Now Embraced By Most

 
• By Malcolm Spicer

Limits so effective that states are relaxing restrictions they previously set exceeding the nationwide limit Congress imposed in Combat Meth Act in 2006 on the amount of PSE, as well as a second meth precursor, ephedrine, in OTC drugs consumers can purchase daily.

Iberogast Helps With Dyspepsia-Related Bloating – Bayer Study

 
• By David Ridley

A recently publshed, Bayer-supported, randomized, double-blind study found that functional dyspepsia sufferers using Iberogast reported feeling less full and bloated compared to those on a placebo.